Summit Therapeutics Common Stock Net 2015-2025 | SMMT

Summit Therapeutics common stock net for the quarter ending March 31, 2025 was $0.007B, a 5.64% increase year-over-year.

  • Summit Therapeutics common stock net for 2024 was $0.007B, a 5.12% increase from 2023.
  • Summit Therapeutics common stock net for 2023 was $0.007B, a 232.56% increase from 2022.
  • Summit Therapeutics common stock net for 2022 was $0.002B, a 115.31% increase from 2021.

Summit Therapeutics Common Stock Net 2015-2025 | SMMT

  • Summit Therapeutics common stock net for 2024 was $0.007B, a 5.12% increase from 2023.
  • Summit Therapeutics common stock net for 2023 was $0.007B, a 232.56% increase from 2022.
  • Summit Therapeutics common stock net for 2022 was $0.002B, a 115.31% increase from 2021.